Daito Pharmaceutical Co.,Ltd.

TSE:4577 Lagerbericht

Marktkapitalisierung: JP¥34.0b

Daito PharmaceuticalLtd Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

Daito PharmaceuticalLtd's earnings have been declining at an average annual rate of -5%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 0.2% per year. Daito PharmaceuticalLtd's return on equity is 5.7%, and it has net margins of 6.8%.

Wichtige Informationen

-5.0%

Wachstumsrate der Gewinne

-7.9%

EPS-Wachstumsrate

Pharmaceuticals Wachstum der Industrie3.4%
Wachstumsrate der Einnahmen0.2%
Eigenkapitalrendite5.7%
Netto-Marge6.8%
Letzte Ertragsaktualisierung31 Aug 2024

Jüngste Aktualisierungen vergangener Leistungen

Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 19
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 19
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Aufschlüsselung der Einnahmen und Ausgaben

Wie Daito PharmaceuticalLtd Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

TSE:4577 Einnahmen, Ausgaben und Erträge (JPY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
31 Aug 2447,3953,2303,4382,349
31 May 2446,8953,2953,4312,349
29 Feb 2445,1933,2793,4121,865
30 Nov 2345,8443,3903,3881,865
31 Aug 2345,2383,3373,1961,865
31 May 2345,1013,6003,0781,865
28 Feb 2344,4513,3503,3721,749
30 Nov 2244,3683,6533,3991,749
31 Aug 2243,7593,7893,3491,749
31 May 2243,4644,6682,9901,749
28 Feb 2244,4624,5252,6582,032
30 Nov 2145,1424,6002,5612,032
31 Aug 2146,7574,7502,4362,032
31 May 2148,7144,2462,7122,032
28 Feb 2148,4544,4023,1751,400
30 Nov 2047,7734,3653,0131,400
31 Aug 2047,0364,3452,9261,400
31 May 2044,9913,9442,6091,400
29 Feb 2045,1054,2042,3661,608
30 Nov 1944,2423,8422,2511,608
31 Aug 1943,0533,6542,2831,608
31 May 1941,1343,5132,3941,608
28 Feb 1940,6403,2912,3001,522
30 Nov 1839,5663,1272,4051,522
31 Aug 1839,9333,1472,2461,522
31 May 1839,8753,0412,3011,522
28 Feb 1839,7012,9132,5541,266
30 Nov 1739,2192,8202,4141,266
31 Aug 1738,5542,6582,5421,266
31 May 1737,9842,6562,3941,266
28 Feb 1737,2832,6982,5231,174
30 Nov 1637,2702,7222,4381,174
31 Aug 1636,7472,5592,2821,174
31 May 1636,3702,5662,3481,174
29 Feb 1636,4162,6392,1071,182
30 Nov 1535,6912,4032,3581,182
31 Aug 1535,3702,4682,3531,182
31 May 1534,0582,2462,2431,182
28 Feb 1533,7652,0802,531890
30 Nov 1432,5282,0102,168890
31 Aug 1431,5601,8642,033890
31 May 1431,1961,8112,029890
28 Feb 1429,8761,9101,7511,113
30 Nov 1329,6801,7871,8711,113

Qualität der Erträge: 4577 has high quality earnings.

Wachsende Gewinnspanne: 4577's current net profit margins (6.8%) are lower than last year (7.4%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 4577's earnings have declined by 5% per year over the past 5 years.

Beschleunigtes Wachstum: 4577's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Erträge im Vergleich zur Industrie: 4577 had negative earnings growth (-3.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (38.7%).

Eigenkapitalrendite

Hohe Eigenkapitalrendite: 4577's Return on Equity (5.7%) is considered low.

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

7D

1Y

7D

1Y

7D

1Y